{"entity":{"type":"insider","cik":"0001991787","url":"/insider/0001991787","json_url":"/insider/0001991787.json","name":"Bala Mohan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2023-10-27","last":"2025-10-28","span_basis":"filed_date"},"name_variants":[{"name":"Bala Mohan","source":"filing","n_filings":7,"first_seen":"2023-10-27","last_seen":"2025-10-28"}],"transactions":[{"id":4549438,"accession":"0001104659-25-103170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-103170","line_url":"/filing/0001104659-25-103170#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77.0,"shares_display":"77","price_per_share":9.9,"price_display":"9.90","price_state":"stated","total_value":762.3,"total_display":"762.30","total_whole":"762","shares_owned_after":2922.0,"shares_owned_after_display":"2,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-27","filed_date":"2025-10-28","scope":"insider"},{"id":4266845,"accession":"0001104659-25-004590","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-004590","line_url":"/filing/0001104659-25-004590#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5939.0,"shares_display":"5,939","price_per_share":0.58,"price_display":"0.58","price_state":"stated","total_value":3444.62,"total_display":"3,444.62","total_whole":"3,445","shares_owned_after":68872.0,"shares_owned_after_display":"68,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":4468928,"accession":"0001104659-25-003874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-003874","line_url":"/filing/0001104659-25-003874#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3253.0,"shares_display":"3,253","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":2146.98,"total_display":"2,146.98","total_whole":"2,147","shares_owned_after":60228.0,"shares_owned_after_display":"60,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-14","filed_date":"2025-01-15","scope":"insider"},{"id":2419174,"accession":"0001104659-24-112267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-112267","line_url":"/filing/0001104659-24-112267#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1884.0,"shares_display":"1,884","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":3579.6,"total_display":"3,579.60","total_whole":"3,580","shares_owned_after":54731.0,"shares_owned_after_display":"54,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-29","scope":"insider"},{"id":2147106,"accession":"0001104659-24-106749","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-106749","line_url":"/filing/0001104659-24-106749#line-3","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5598.0,"shares_display":"5,598","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":10972.08,"total_display":"10,972.08","total_whole":"10,972","shares_owned_after":50365.0,"shares_owned_after_display":"50,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-07","scope":"insider"},{"id":2147105,"accession":"0001104659-24-106749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-106749","line_url":"/filing/0001104659-24-106749#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8089.0,"shares_display":"8,089","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":16178.0,"total_display":"16,178.00","total_whole":"16,178","shares_owned_after":55963.0,"shares_owned_after_display":"55,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-07","scope":"insider"},{"id":2184035,"accession":"0001104659-24-004540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-004540","line_url":"/filing/0001104659-24-004540#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3431.0,"shares_display":"3,431","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":9298.01,"total_display":"9,298.01","total_whole":"9,298","shares_owned_after":14052.0,"shares_owned_after_display":"14,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8225077,"accession":"0001104659-23-112168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-112168","line_url":"/filing/0001104659-23-112168#line-2","is_derivative":false,"issuer_cik":"0001442836","issuer_name":"Mersana Therapeutics, Inc.","issuer_ticker":"MRSN","issuer_name_source":null,"issuer_url":"/issuer/0001442836","owner_cik":"0001991787","owner_name":"Bala Mohan","owner_display_name":"Bala Mohan","owner_url":"/insider/0001991787","role":"Officer (SVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1912.0,"shares_display":"1,912","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":2160.56,"total_display":"2,160.56","total_whole":"2,161","shares_owned_after":8733.0,"shares_owned_after_display":"8,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-26","filed_date":"2023-10-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001442836","name":"Mersana Therapeutics, Inc.","url":"/issuer/0001442836","role":"Officer (SVP, Chief Development Officer)","n_filings":7,"first_seen":"2023-10-27","last_seen":"2025-10-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001991787","retrieved_at":"2026-08-24T10:15:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}